Journals / Şişli Etfal Hastanesi Tıp Bülteni / 2014 / Cilt: 48 - Sayı: 3

The relationship of hs-CRP with regulation of hypertension in patients who have both Type 2 diabetes mellitus and hypertension

Hipertansif Tip 2 Diabetes Mellitus'lu hastalarda tansiyon regülasyonunun yüksek duyarlıklı C-reaktif protein (hs-CRP) ile ilişkisi

Pages
182–187
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Also, there was no statistically significant difference between the groups in terms of hs-CRP.Conclucion: Patients with type 2 diabetes mellitus who have hypertension, it was determined that controlling the blood pressure did not constitute a significant difference in hs-CRP levels.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: In different studies, it was determined that diabetes mellitus and hypertension can increase hs-CRP levels.
📊
Key Findings & Data:In this study, we aim to compare the levels of hs-CRP between 2 groups with controlled or uncontrolled hypertension in patients who have both type 2 diabetes mellitus and hypertension.Material and Method: We enrolled 64 female and 65 male, total 129 patient, into the study who admitted to our diabetes polyclinic between 2010 May and 2010 September.
💡
Conclusion & Impact:Also, there was no statistically significant difference between the groups in terms of hs-CRP.Conclucion: Patients with type 2 diabetes mellitus who have hypertension, it was determined that controlling the blood pressure did not constitute a significant difference in hs-CRP levels.
🔬Design:Research Article
📍Scope:2010 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: In different studies, it was determined that diabetes mellitus and hypertension can increase hs-CRP levels. In this study, we aim to compare the levels of hs-CRP between 2 groups with controlled or uncontrolled hypertension in patients who have both type 2 diabetes mellitus and hypertension.Material and Method: We enrolled 64 female and 65 male, total 129 patient, into the study who admitted to our diabetes polyclinic between 2010 May and 2010 September. Patient's sociodemographic properties, detailed histories, drug usage, anthropometric measures, physical examination findings and laboratuary results were investigated. Situations that affect CRP levels were excluded from the study. In this study, level of significance was considered to be p<0.05.Results: In the study, 49.6% (n=64) of patients were female, and 50.4% (n=65) were male. Those who have regulated blood pressure was 65 (50.4%) and who have not regulated blood pressure was 64 (49.6%) people. Mean body mass index was 30.17±5.30 kg/m2. The mean duration of diabetes was 6.69±4.57 years, the mean duration of hypertension was 6.38±4.41 years. Those who have regulated hypertension, mean body mass index was 29.81±5.44, who have not regulated hypertension was 30.53±5.18. There was no statistically significant difference between the groups in terms of gender (p>0.05). There was no statistically significant difference between the groups in terms of HbA1c, total cholesterol, HDL- cholesterol, LDL- cholesterol, VLDL- cholesterol, triglyceride, TSH, fasting blood glucose, postprandial blood glucose, AST, ALT, proteinuria ve creatinine. Also, there was no statistically significant difference between the groups in terms of hs-CRP.Conclucion: Patients with type 2 diabetes mellitus who have hypertension, it was determined that controlling the blood pressure did not constitute a significant difference in hs-CRP levels.

Özet

Amaç: Diabet ve hipertansiyonun, değişik çalışmalarla hs-CRP'yi artırdığı saptanmıştır. Biz bu çalışmayla tip 2 diabetli hipertansif olgularda tansiyonu kontrol altında olan ve olmayan 2 grup arasında hs-CRP düzeylerini karşılaştırmayı hedefledik. Gereç ve Yöntem: Çalışmamıza 2010 Mayıs-2010 Eylül tarihleri arasında diabet polikliniğimize başvuran 64'ü kadın, 65'i erkek olmak üzere toplam 129 olgu alındı. Çalışmaya alınan olguların, sosyodemografik özellikleri, detaylı öyküleri, antropometrik ölçümleri, fizik muayene bulguları, laboratuvar tetkikleri incelendi. CRP değerini etkileyen durumları olan olgular çalışma dışı tutuldu. Çalışmamızda anlamlılık düzeyi p 0.05). Laboratuar bulgularından hs-CRP, HbA1c, total kolesterol, HDL, LDL, VLDL, trigliserid, TSH, açlık kan glukozu, tokluk kan glukozu, AST, ALT, proteinüri ve kreatinin ölçümlerinde tansiyonu regüle olan ve olmayanlar arasında anlamlı farklılık görülmedi (p>0.05). Sonuç: Tip 2 diabetes mellitus tanılı hipertansiyonu olan olgularda tansiyonu kontrol altına almanın hs-CRP düzeyi açısından anlamlı farklılık oluşturmadığı saptanmıştır.

🔖

Cite This Article

BAŞER, M., ÖZGÜR, R., MAVİŞ, O., ÖZDEMİR, A. A., ÖZKESKİN, A., KÜÇÜKDEMİRCİ, Ö., ELİBOL, T. (2014). The relationship of hs-CRP with regulation of hypertension in patients who have both Type 2 diabetes mellitus and hypertension. Şişli Etfal Hastanesi Tıp Bülteni, Cilt: 48 - Sayı: 3, 182–187. https://ajindex.com/articles/363814

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Powers AC. Diabetes Mellitus. In: Braunwald E, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL(eds). Harrison's Principles of Internal Medicine, 15th edition. Philadelphia: Mc Graw Hill Compan;y 2001. p. 2109-38
  2. İmamoğlu S. Diabetes Mellitus. Dolar E (editör). İç Hastalıkları. İstanbul: Nobel&Günes Tıp Kitabevi; 2000. P. 692-719
  3. Altuntas Y. Diabetes Mellitus'un Tanımı, Tanısı ve Sınıflanması, Her Yönüyle Diabetes Mellitus. Yenigün M, Altuntas Y (editör). İstanbul: Nobel Tıp Kitabevleri; 2001. P. 51-62
  4. Gill G, Pickup J, Williams G. Difficult Diabetes. 2001, 1st edition. Çev: Uslan İ, Diyabet ve Zorlukları, And Yayıncılık; 2002. P. 3-19
  5. Hernandez-Hernandez R, Armas-Padilla MC, Velasco M, Carvajal AR, de Hernandez MJA, Guerrero-Pajuelo J, et al. Effects of amlodipin and enalapril on platelet function in patients with mild to moderate hypertension. Int J Clin Pharmacol Ther.1999; 37: 323-31
  6. Tsunoda K, Arita K, Yukawa M, Ueyama M, Furuta M, Nakagawa T, et al. Retinopathy and hypertension affect serum highsensitivity C-reactive protein levels in Type 2 diabetic patients. J Diabetes Complications 2005; 19: 123-7
  7. Lemieux I, Pascot A, Prud'homme D, et al. Elevated C-reactive protein. Another component of the atherothrombotic profile of abdominal obesity. Arterioscler Thromb Vasc Biol 2001; 21: 961-7
  8. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Eng J Med 2000; 342: 836-43
  9. Rifai N, Tracy RP, Ridker PM. Clinical efficacy of an automated high-sensitivity C-reactive protein assay. Clin Chem 1999; 45: 2136-41
  10. Kearney PM, Whelton M, Reynolds K, Whelton PK, He J. Worldwide prevalence of hypertension: a systematic review. J Hypertens 2004; 22: 11-9
  11. Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289: 2560-72
  12. Altun B, Arıcı M, Nergizoğlu G, Derici U, Karatan O, Turgan Ç, et al. The Turkish Society of Hypertension and Renal Diseases. Prevalence, awareness, treatment and control of hypertension in Turkey (the PatenT study) in 2003. J Hypertens 2005; 23: 1817-23
  13. Gomes MB, Piccirillo LJ, Noguiera VG, Matos HJ; Acute-phase proteins among patients with type 1 diabetes. Diabetes Metab. 2003; 29(4 Pt 1): 405-11
  14. Lima LM, Carvalho MG, Soares AL, Sabino Ade P, Fernand